Withings ScanWatch is currently being tested by a number of French hospitals for patients’ COVID19 home monitoring. The device is still pending clearances from regulators and should be available to all by the end of Q2.
Unveiled at CES 2020, the hybrid is some two year in the making. Its headline feature is the ability to spot a serious form of irregular heart rhythm that can lead to heart failure and is a major risk for stroke. Some people who have AFib don’t have any symptoms, so the condition often goes undiagnosed. Others may experience dizziness, weakness and fatigue. It is the first of these two groups which is particularly at risk.
Scanwatch has a PPG sensor that is… READ MORE @ gadgetsandwearables.com